Regulatory actions for Aug. 3, 2026Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abivax, ABL, Astrazeneca, Daiichi Sankyo, Fresenius, Karyopharm, Lupin, Meitheal, Polpharma, Replimune, Total Flow Medical.